3830
H. Zuo et al. / Tetrahedron Letters 49 (2008) 3827–3830
Cl
Bn
NH
O
HO
Cl
Cl
Cl
O
O
NHBn
Cl
Cl
1e
BnNH2
O
Cl
Cs2CO3
2a
Cl
N
H
O
H
O
O
Cs2CO3
- HCl
-Cl
Cl
O
N
Bn
Cl
O
N
Bn
Cl
Bn
O
3o
Scheme 3. Proposed mechanism.
S. G.; Giester, G.; Leban, I.; Kikelj, D. J. Org. Chem. 2001, 66, 7044;
(d) Lee, C. L.; Chan, K. P.; Lam, Y.; Lee, S. Y. Tetrahedron Lett.
2001, 42, 1167; (e) Achari, B.; Mandal, S. B.; Dutta, P. K.;
Chowdhury, C. Synlett 2004, 2449.
Acknowledgement
This work was supported by Grants from the Korea
Research Foundation (KRF200-005-D20016).
¨
¨
11. (a) Ozden, S.; Ozturk, A. M.; Go¨ker, H.; Altanlar, N. Il Farmaco
¨
´
2000, 55, 715; (b) Arrault, A.; Touzeau, F.; Guillaumet, G.; Leger, J.-
Supplementary data
´
M.; Jarry, C.; Merour, J.-Y. Tetrahedron 2002, 58, 8145.
12. Dai, W.-M.; Wang, X.; Ma, C. Tetrahedron 2005, 61, 6879 and
references cited therein.
13. Yuan, Y. Y.; Liu, G.; Li, L.; Wang, Z. G.; Wang, L. J. Comb. Chem.
2007, 9, 158.
Supplementary data associated with this article can be
14. Baker, W. R. J. Org. Chem. 1983, 48, 5140.
15. (a) Ma, C.; Cho, S.-D.; Falck, J. R.; Shin, D.-S. Heterocycles 2004,
63, 75; (b) Cho, S.-D.; Song, S.-Y.; Park, Y.-D.; Kim, J.-J.; Joo,
W.-H.; Shiro, M.; Falck, J. R.; Shin, D.-S.; Yoon, Y.-J. Tetrahedron
Lett. 2003, 44, 8995; (c) Cho, S.-D.; Park, Y.-D.; Kim, J.-J.; Joo,
W.-H.; Shiro, M.; Esser, L.; Falck, J. R.; Ahn, C.; Shin, D.-S.; Yoon,
Y.-J. Tetrahedron 2004, 60, 3763; (d) Cho, S.-D.; Park, Y.-D.; Kim,
J.-J.; Lee, S.-G.; Ma, C.; Song, S.-Y.; Joo, W.-H.; Falck, J. R.; Shiro,
M.; Yoon, Y.-J.; Shin, D.-S. J. Org. Chem. 2003, 68, 7918; (e) Shin,
D.-S.; Park, J. K. Bull. Korean Chem. Soc. 2007, 28, 2219.
References and notes
1. Smid, P.; Coolen, H. K. A. C.; Keizer, H. G.; van Hes, R.; de Moes,
J.-P.; den Hartog, A. P.; Stork, B.; Plekkenpol, R. H.; Niemann, L.
C.; Stroomer, C. N. J.; Tulp, M. Th. M.; van Stuivenberg, H. H.;
McCreary, A. C.; Hesselink, M. B.; Herremans, A. H. J.; Kruse, C. G.
J. Med. Chem. 2005, 48, 6855.
2. Fringuelli, R.; Pietrella, D.; Schiaffella, F.; Guarraci, A.; Perito, S.;
Bistoni, F.; Vecchiarelli, A. Bioorg. Med. Chem. 2002, 10, 1681.
3. Macchiarulo, A.; Costantino, G.; Fringuelli, D.; Vecchiarelli, A.;
Schiaffella, F.; Fringuelli, R. Bioorg. Med. Chem. 2002, 10, 3415.
4. Lanni, T. B., Jr.; Greene, K. L.; Kolz, C. N.; Para, K. S.; Visnick, M.;
Mobley, J. L.; Dudley, D. T.; Baginski, T. J.; Liimatta, M. B. Bioorg.
Med. Chem. Lett. 2007, 17, 756.
5. Huang, M.-Z.; Huang, K.-L.; Ren, Y.-G.; Lei, M.-X.; Huang, L.;
Hou, Z.-K.; Liu, A.-P.; Qu, X.-M. J. Agric. Food Chem. 2005, 53,
7908.
6. Caliendo, G.; Perissutti, E.; Santagada, V.; Ferdinando, F.; Severino,
B.; d’Emmanuele di Villa Bianca, R.; Lippolis, L.; Pinto, A.;
Sorrentinio, R. Bioorg. Med. Chem. 2002, 10, 2663.
16. General experimental procedure: To a magnetically stirred solution of
the appropriate amine 2 (1.0 mmol) and Cs2CO3 (3.6 mmol) in dry
DMF (10 mL) cooled by ice bath, were added chloroacetyl chloride
(1.1 mmol) and 1 (0.8 mmol). The reaction mixture was then placed
into microwave oven (KMIC-1.5 kW) at 150 °C and irradiated for the
period listed in Table 1. After completion of the reaction (monitored
by TLC), the solvent was removed under vacuum and the residue was
poured into water (20 mL). The aqueous solution was then extracted
by ethyl acetate (4 Â 30 mL) and the combined organic layers were
dried over anhydrous MgSO4. The solvent was removed under
vacuum to obtain the crude product which was purified by column
chromatography (silica gel) to afford the desired pure compound.
Spectral data of the selected product (3b): White solid, mp: 116–
118 °C; IR (m cmÀ1): 3078, 3032, 3001, 2951, 2901, 1688, 1585, 1501,
1496, 1412, 1362, 1291, 1242, 1192, 1143, 1085, 1042, 880, 870, 853,
ˇ
7. Anderluh, M.; Cesar, J.; Stefanicˇ, P.; Kikelj, D.; Janesˇ, D.; Murn, J.;
Nadrah, K.; Tominc, M.; Addicks, E.; Giannis, A.; Stegnar, M.;
Dolenc, M. S. Eur. J. Med. Chem. 2005, 40, 25.
8. Scheunemann, M.; Sorger, D.; Kouznetsova, E.; Sabri, O.; Schliebs,
R.; Wenzel, B.; Steinbach, J. Tetrahedron Lett. 2007, 48,
5497.
1
794, 734, 704, 534; H NMR (400 MHz, CDCl3): d 4.73 (s, 2H), 5.13
(s, 2H), 6.72 (d, J = 8.8 Hz, 1H), 7.00 (dd, J = 8.8, 2.0 Hz, 1H), 7.14
(d, J = 2.0 Hz, 1H), 7.21–7.34 (m, 5H); 13C NMR (100 MHz, CDCl3):
d 45.0, 67.7, 116.1, 116.9, 120.3, 125.7, 126.6, 127.7, 128.0, 129.0,
135.4, 146.0, 164.2; MS (EI) m/z: 317 (M+, 77%), 198 (6), 170 (6), 91
(100), 65 (23); Anal. Calcd for C15H12BrNO2 (318): C, 56.62; H, 3.80;
N, 4.40. Found: C, 56.51; H, 3.70; N, 4.51.
9. Bakker, C.U.S. Patent 2005209228, 2005.
10. (a) Breznik, M.; Mrcina, A.; Kikelj, D. Tetrahedron: Asymmetry 1998,
9, 1115; (b) Breznik, M.; Hrast, V.; Mrcina, A.; Kikelj, D.
Tetrahedron: Asymmetry 1999, 10, 153; (c) Breznik, M.; Grdadolnik,